Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBurberry Regulatory News (BRBY)

Share Price Information for Burberry (BRBY)

Share Price is delayed by 15 minutes
Get Live Data
1,108.50    25.50 (2.35%)
Bid:
1,113.50
Ask:
1,114.00
Spread: 0.50 (0.045%)
Market Cap: £3.98b
BRBY Live PriceLast checked at - London Stock Exchange

Intraday Burberry Share Chart

Director/PDMR Shareholding

26 Jun 2017 17:21

RNS Number : 2097J
Burberry Group PLC
26 June 2017
 

Burberry Group plc (the "Company") - Director/PDMR Shareholdings

 

The Company announces that on 26 June 2017 Julie Brown, a director of the Company, decided to waive 75% (94,860 shares) of the Executive Share Plan award she was granted on 30 January 2017 ("ESP 2016/17") due to the overlap of the 2016/17 performance period and 47,099 of nil cost options she was granted on 30 January 2017 (the "buy-out award") in the light of the vesting outcome of her 2014 award from her former employer. The Remuneration Committee welcomed and agreed with her decision.

 

The surrender caused the ESP 2016/17 nil-cost options to immediately lapse in respect of 94,860 shares. Julie continues to hold nil-cost options over the balance, being 31,620 shares under the ESP 2016/17.

 

Additionally, the surrender caused the buy-out award nil-cost options to immediately lapse in respect of 47,099 shares. Julie continues to hold nil-cost options over the balance, being 167,901 shares, which will vest (subject to continued employment) as follows:

 

· On 22 July 2017 - 38,901 shares;

· On 22 July 2018 - 64,500 shares;

· On 22 July 2019 - 64,500 shares.

The Company has also today disclosed on its website (www.burberryplc.com) within the Corporate Governance section) additional information relating to the assessment of performance for 2016/17 in respect of Christopher Bailey's 2014 Exceptional Performance-Based Award.

26 June 2017

The following disclosures are made in accordance with Article 19.3 of the EU Market Abuse Regulation 596/2014.

1

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

Julie Brown

2

Reason for the notification

a)

Position/status

Chief Operating and Financial Officer

b)

Initial notification /Amendment

Initial notification

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Burberry Group plc

b)

LEI

N/A

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument

Identification code

Ordinary shares of 0.05 pence each

 

 

GB0031743007

b)

Nature of the transaction

Surrender (for nil consideration) of nil-cost options over:

(i) 94,860 shares that were granted on 30 January 2017 under the Executive Share Plan; and

(ii) 47,099 shares that were granted on 30 January 2017 as compensation for the incentives Julie Brown forfeited on leaving her previous employer.

c)

Price(s) and volume(s)

 

Price(s)

Volume(s)

Nil

94,860

Nil

47,099

 

d)

Aggregated information

 

- Aggregated volume

 

- Price

 

 

Aggregate Price

Aggregate Volume

Aggregate

Total

Nil

141,959

Nil

e)

Date of the transaction

2017-06-26

 

f)

Place of the transaction

Outside a trading venue

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
DSHLLFLRRAIRFID
Date   Source Headline
27th Jul 20212:44 pmRNSDirector/PDMR Shareholding
16th Jul 20217:00 amRNSBurberry 1st Quarter Trading Update
14th Jul 20215:40 pmRNSResult of AGM
13th Jul 20212:15 pmRNSBoard Change
1st Jul 202110:30 amRNSTotal Voting Rights
28th Jun 20217:00 amRNSBoard Change
2nd Jun 20212:58 pmRNSAnnual Financial Report
1st Jun 202112:00 pmRNSTotal Voting Rights
17th May 20215:50 pmRNSDirector/PDMR Shareholding
13th May 20217:00 amRNSBurberry Preliminary Results
4th May 202112:30 pmRNSTotal Voting Rights
1st Apr 202111:00 amRNSTotal Voting Rights
12th Mar 20217:00 amRNSStatement re Burberry Trading Update
1st Mar 20214:30 pmRNSBlock listing Interim Review
1st Mar 202112:30 pmRNSTotal Voting Rights
11th Feb 20214:40 pmRNSDirector/PDMR Shareholding
1st Feb 20212:00 pmRNSTotal Voting Rights
20th Jan 20217:00 amRNSBurberry 3rd Quarter Trading Update
4th Jan 202112:00 pmRNSTotal Voting Rights
16th Dec 20203:24 pmRNSDirector/PDMR Shareholding
11th Dec 202012:15 pmRNSDirector/PDMR Shareholding
1st Dec 202010:15 amRNSTotal Voting Rights
23rd Nov 20201:17 pmRNSBoard Changes
17th Nov 202012:16 pmRNSDirector/PDMR Shareholding
12th Nov 20207:00 amRNSBurberry Interim Results
2nd Nov 202012:30 pmRNSTotal Voting Rights
1st Oct 20201:15 pmRNSTotal Voting Rights
21st Sep 20203:11 pmRNSPublication of a Prospectus
15th Sep 20209:00 amRNSBurberry Final Terms Inaugural Sustainability Bond
15th Sep 20207:50 amRNSStabilisation Notice
14th Sep 20209:03 amRNSStabilisation Notice
9th Sep 20209:02 amRNSBurberry Inaugural Medium-Term Sustainability Bond
1st Sep 20202:30 pmRNSBlock listing Interim Review
1st Sep 202011:45 amRNSTotal Voting Rights
21st Aug 202012:45 pmRNSBlock Listing Application
21st Aug 202010:00 amRNSDirector/PDMR Shareholding
12th Aug 20204:22 pmRNSDirector Declaration
6th Aug 20203:16 pmRNSDirector/PDMR Shareholding
3rd Aug 202010:30 amRNSTotal Voting Rights
29th Jul 202012:19 pmRNSDirector/PDMR Shareholding
15th Jul 202012:49 pmRNSResult of AGM
15th Jul 20207:00 amRNSBurberry 1st Quarter Trading Update
1st Jul 202011:58 amRNSTotal Voting Rights
12th Jun 20209:30 amRNSDirector/PDMR Shareholding
10th Jun 20206:14 pmRNSAnnual Financial Report
1st Jun 202010:55 amRNSTotal Voting Rights
22nd May 20201:31 pmRNSBoard Changes
22nd May 20207:00 amRNSBurberry Preliminary Results 2020
1st May 20209:30 amRNSTotal Voting Rights
27th Apr 20203:10 pmRNSDISCLOSURE OF RIGHTS ATTACHED TO EQUITY SHARES

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.